The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,711.00
Bid: 3,717.00
Ask: 3,718.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.027%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,711.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Notes

4 Dec 2019 10:00

RNS Number : 6378V
Experian plc
04 December 2019
 

Experian plc

 

 

Issue of Notes

 

 

4 December 2019 - Experian plc, the global information services company, announces that its subsidiary, Experian Finance plc, has priced an issue of US$750m 2.75% notes due 2030 (the "Notes"), expected to be rated A-/Baa1. The Notes will be issued by Experian Finance plc and guaranteed by Experian plc.

 

The net proceeds of the offering will be used for general corporate purposes including potential acquisitions and the repayment of debt. The issue is scheduled to close on 10 December 2019, subject to customary conditions.

 

It is expected that the Notes will be admitted to the official list of Euronext Dublin and admitted to trading on the Global Exchange Market.

 

The Notes are being sold to qualified institutional buyers in the United States in accordance with Rule 144A under the US Securities Act of 1933 ("Securities Act"), and to persons outside the United States in reliance upon Regulation S under the Securities Act. The Notes and the guarantee have not been, and will not be, registered under the Securities Act, or the securities laws of any state of the United States or other jurisdiction, and may not be offered or sold in the United Sates, or to, or for the account or benefit of, US persons, other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

 

This announcement does not constitute or form part of any offer or any solicitation to purchase nor shall it, or the fact of its distribution, form the basis of, or be relied on in any purchase. The distribution of this announcement and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this announcement or any subsequent offer should inform themselves about and observe any such restriction. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

 

 

Contact:

 

Experian

Antony Barnes Director of Corporate Finance +44 (0)20 3042 4215

Nadia Ridout-Jamieson Chief Communications Officer

 

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 17,200 people operating across 44 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODMMMGZLDNGLZG
Date   Source Headline
7th Jun 20233:49 pmRNSDirector/PDMR Shareholding
2nd Jun 20239:00 amRNSElections for second interim dividend
31st May 20231:12 pmRNSTotal Voting Rights
31st May 20239:32 amRNSAdditional Listing
22nd May 202312:46 pmRNSDirector/PDMR Shareholding
18th May 20232:29 pmRNSDirector/PDMR Shareholding
18th May 202310:20 amRNSDirector/PDMR Shareholding
17th May 20234:00 pmRNSDirector/PDMR Shareholding
17th May 202311:00 amRNSShare repurchases
17th May 20237:00 amRNSFull-year financial report
28th Apr 202310:15 amRNSTotal Voting Rights
12th Apr 20239:30 amRNSAdditional Listing
4th Apr 20239:45 amRNSAdditional Listing
31st Mar 202311:35 amRNSTotal Voting Rights
29th Mar 20239:20 amRNSAdditional Listing
28th Mar 20237:00 amRNSDirectorate Change
22nd Mar 20235:19 pmRNSTransaction in Own Shares
22nd Mar 20239:15 amRNSAdditional Listing
20th Mar 20235:18 pmRNSTransaction in Own Shares
17th Mar 20235:31 pmRNSTransaction in Own Shares
16th Mar 20235:09 pmRNSTransaction in Own Shares
16th Mar 20239:15 amRNSBlock listing Interim Review
15th Mar 20235:14 pmRNSTransaction in Own Shares
15th Mar 20239:15 amRNSAdditional Listing
14th Mar 20235:21 pmRNSTransaction in Own Shares
13th Mar 20235:31 pmRNSTransaction in Own Shares
10th Mar 20236:10 pmRNSTransaction in Own Shares
9th Mar 20235:22 pmRNSTransaction in Own Shares
8th Mar 20235:21 pmRNSTransaction in Own Shares
8th Mar 20239:15 amRNSAdditional Listing
7th Mar 20235:26 pmRNSTransaction in Own Shares
1st Mar 202312:00 pmRNSDirector/PDMR Shareholding
1st Mar 20239:15 amRNSAdditional Listing
28th Feb 202312:20 pmRNSTotal Voting Rights
22nd Feb 202310:00 amRNSAdditional Listing
15th Feb 202310:45 amRNSAdditional Listing
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20239:30 amRNSAdditional Listing
1st Feb 20239:15 amRNSAdditional Listing
31st Jan 20232:30 pmRNSDirector Declaration
31st Jan 202310:15 amRNSTotal Voting Rights
25th Jan 20239:15 amRNSAdditional Listing
17th Jan 20237:00 amRNSExperian Q3 FY23 trading update
13th Jan 20235:20 pmRNSFirst interim dividend
9th Jan 20237:00 amRNSDirectorate Change
30th Dec 202210:15 amRNSTotal Voting Rights
16th Dec 202211:30 amRNSElections for first interim dividend
14th Dec 20229:15 amRNSAdditional Listing
7th Dec 20229:00 amRNSAdditional Listing
30th Nov 202211:59 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.